India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
Weekly Current Affairs One-Liners Current Affairs 2025 plays a very important role in competitive examinations…
The Ministry of Electronics and Information Technology (MeitY) has launched ‘PARAM SHAKTI’, a powerful new…
Akasa Air, India’s youngest airline founded in 2020, has become a member of the International…
The Government of India focuses strongly on the welfare and empowerment of women and children.…
The 53rd edition of the New Delhi World Book Fair (NDWBF) 2026 will be held…
The 98th Academy Awards, also known as Oscars 2026, have recognized five Indian films as…